Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krassen Nedeltchev

Showing results (1-10 of 142) with videos related to

Pageof 15
Sort By:
Stroke|February 7, 2012
Critique of apixaban versus warfarin in patients with atrial fibrillationKrassen Nedeltchev
Frontiers of Neurology and Neuroscience|February 10, 2007
Contrast-enhanced transcranial Doppler ultrasound for diagnosis of patent foramen ovaleKrassen Nedeltchev, Heinrich P Mattle
Therapeutische Umschau. Revue Therapeutique|April 3, 2019
[Secondary prevention of ischemic stroke: overview of updated guidelines]Smaila Mulic, Timo Kahles, Krassen Nedeltchev
Stroke|December 3, 2011
Letter by Nedeltchev et al regarding article, "Short-term outcomes after symptomatic internal carotid artery occlusion"Krassen Nedeltchev, Luca Remonda, Gerhard Schroth
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 27, 2007
Patent foramen ovale closure: a new therapy for migraineMarkus Schwerzmann, Krassen Nedeltchev, Bernhard Meier
Brain Communications|May 8, 2023
Spike-microstates correlate with interictal epileptogenic discharges: a marker for hidden epileptic activityVincent Rochas, Markus Gschwind, Krassen Nedeltchev, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
Oral disease modifying therapies - A game changer for treatment decision in untreated patients with RRMS and CIS? - A swiss single center cross-sectional studySebastian Finkener, Lutz Achtnichts, Michaela Cervenakova, et al.
Therapeutic Advances in Neurological Disorders|August 18, 2018
Long-term evaluation of NEDA-3 status in relapsing-remitting multiple sclerosis patients after switching from natalizumab to fingolimodLara Diem, Krassen Nedeltchev, Timo Kahles, et al.
JAMA Neurology|October 13, 2015
Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With FingolimodLutz Achtnichts, Otilia Obreja, Anna Conen, et al.
Journal of Neurology|March 6, 2007
Low awareness of transient ischemic attacks and risk factors of stroke in a Swiss urban communityKrassen Nedeltchev, Urs Fischer, Marcel Arnold, et al.
Pageof 15

Showing results (1-10 of 142) with videos related to

Sort By:
Pageof 15
Stroke|February 7, 2012
Critique of apixaban versus warfarin in patients with atrial fibrillationKrassen Nedeltchev
Frontiers of Neurology and Neuroscience|February 10, 2007
Contrast-enhanced transcranial Doppler ultrasound for diagnosis of patent foramen ovaleKrassen Nedeltchev, Heinrich P Mattle
Therapeutische Umschau. Revue Therapeutique|April 3, 2019
[Secondary prevention of ischemic stroke: overview of updated guidelines]Smaila Mulic, Timo Kahles, Krassen Nedeltchev
Stroke|December 3, 2011
Letter by Nedeltchev et al regarding article, "Short-term outcomes after symptomatic internal carotid artery occlusion"Krassen Nedeltchev, Luca Remonda, Gerhard Schroth
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|January 27, 2007
Patent foramen ovale closure: a new therapy for migraineMarkus Schwerzmann, Krassen Nedeltchev, Bernhard Meier
Brain Communications|May 8, 2023
Spike-microstates correlate with interictal epileptogenic discharges: a marker for hidden epileptic activityVincent Rochas, Markus Gschwind, Krassen Nedeltchev, et al.
Multiple Sclerosis and Related Disorders|December 22, 2022
Oral disease modifying therapies - A game changer for treatment decision in untreated patients with RRMS and CIS? - A swiss single center cross-sectional studySebastian Finkener, Lutz Achtnichts, Michaela Cervenakova, et al.
Therapeutic Advances in Neurological Disorders|August 18, 2018
Long-term evaluation of NEDA-3 status in relapsing-remitting multiple sclerosis patients after switching from natalizumab to fingolimodLara Diem, Krassen Nedeltchev, Timo Kahles, et al.
JAMA Neurology|October 13, 2015
Cryptococcal Meningoencephalitis in a Patient With Multiple Sclerosis Treated With FingolimodLutz Achtnichts, Otilia Obreja, Anna Conen, et al.
Journal of Neurology|March 6, 2007
Low awareness of transient ischemic attacks and risk factors of stroke in a Swiss urban communityKrassen Nedeltchev, Urs Fischer, Marcel Arnold, et al.
Pageof 15